COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY
申请人:Liu Hong
公开号:US20090247517A1
公开(公告)日:2009-10-01
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).
The invention provides methods and compositions for treating conditions mediated by Bcr-Abl. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.
作者:A. O. Gurenko、S. V. Klyuchko、O. V. Shablykin、V. S. Brovarets
DOI:10.1134/s1070363217100103
日期:2017.10
Acylation and sulfonylation of substituted pyrazolo[3,4-d][1,2,3]triazin-4-ones, as well as reactions with acylating agents proceeding via destruction of the triazine ring are studied.
GARIN, JAVIER;LOSCERTALES, MARIA PILAR;MELENDEZ, ENRIQUE;MERCHAN, FRANCIS+, HETEROCYCLES, 26,(1987) N 5, 1303-1312
作者:GARIN, JAVIER、LOSCERTALES, MARIA PILAR、MELENDEZ, ENRIQUE、MERCHAN, FRANCIS+